{
    "2018-02-02": [
        [
            {
                "time": "",
                "original_text": "豫园股份224亿元重组方案有条件过会 复星大局落下关键一子",
                "features": {
                    "keywords": [
                        "豫园股份",
                        "重组",
                        "复星",
                        "关键一步"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "券商看市：回避地雷股 坚守价值重估",
                "features": {
                    "keywords": [
                        "券商",
                        "地雷股",
                        "价值重估"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药今日大宗交易成交10万股 成交价40.64元 折价0.0%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大宗交易",
                        "成交价"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 医药生物行业深度：CART疗法兴起 生物赛道上的中国机会",
                "features": {
                    "keywords": [
                        "买入评级",
                        "CART疗法",
                        "医药生物",
                        "中国机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星系生物科技公司复宏汉霖或于下半年赴港IPO",
                "features": {
                    "keywords": [
                        "复星系",
                        "复宏汉霖",
                        "IPO",
                        "生物科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "首届C2M智能科技峰会会议程一览",
                "features": {
                    "keywords": [
                        "C2M",
                        "智能科技",
                        "峰会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中银国际港股通每日报告(零售)",
                "features": {
                    "keywords": [
                        "中银国际",
                        "港股通",
                        "零售"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "零售"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 医药生物行业月报：把握政策落地年龙头企业机会 布局年报、一季报业绩预增品种",
                "features": {
                    "keywords": [
                        "增持评级",
                        "医药生物",
                        "政策落地",
                        "龙头企业",
                        "业绩预增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "今日午评：创业板逆境展开反击 上涨 大盘重回3400点",
                "features": {
                    "keywords": [
                        "午评",
                        "创业板",
                        "反击",
                        "大盘",
                        "3400点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股异动︱医药股走强 东瑞制药（02348）涨近6%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药股",
                        "东瑞制药",
                        "涨近6%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "拥抱创新 紧抓医药龙头",
                "features": {
                    "keywords": [
                        "创新",
                        "医药龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[港股] 复星医药附属公司设合资公司 推动大健康AI技术应用",
                "features": {
                    "keywords": [
                        "港股",
                        "复星医药",
                        "合资公司",
                        "大健康AI"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}